These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pharmacokinetics of salicylate ester prodrugs of cyclic HPMPC in dogs. Oliyai R; Arimilli MN; Jones RJ; Lee WA Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1411-4. PubMed ID: 11563033 [TBL] [Abstract][Full Text] [Related]
25. Design of ester prodrugs to enhance oral absorption of poorly permeable compounds: challenges to the discovery scientist. Beaumont K; Webster R; Gardner I; Dack K Curr Drug Metab; 2003 Dec; 4(6):461-85. PubMed ID: 14683475 [TBL] [Abstract][Full Text] [Related]
26. Prodrug design targeting intestinal PepT1 for improved oral absorption: design and performance. Zhang Y; Sun J; Sun Y; Wang Y; He Z Curr Drug Metab; 2013 Jul; 14(6):675-87. PubMed ID: 23869811 [TBL] [Abstract][Full Text] [Related]
27. AS-924, a novel, orally active, bifunctional prodrug of ceftizoxime: physicochemical properties, oral absorption in animals, and antibacterial activity. Mori N; Kodama T; Sakai A; Suzuki T; Sugihara T; Yamaguchi S; Nishijima T; Aoki A; Toriya M; Kasai M; Hatano S; Kitagawa M; Yoshimi A; Nishimura K Int J Antimicrob Agents; 2001 Nov; 18(5):451-61. PubMed ID: 11711261 [TBL] [Abstract][Full Text] [Related]
28. Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs. Shaw JP; Sueoko CM; Oliyai R; Lee WA; Arimilli MN; Kim CU; Cundy KC Pharm Res; 1997 Dec; 14(12):1824-9. PubMed ID: 9453075 [TBL] [Abstract][Full Text] [Related]
29. Oral delivery of anticancer drugs II: the prodrug strategy. Mazzaferro S; Bouchemal K; Ponchel G Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308 [TBL] [Abstract][Full Text] [Related]
30. Species differences in the disposition of propranolol prodrugs derived from hydrolase activity in intestinal mucosa. Yoshigae Y; Imai T; Aso T; Otagiri M Life Sci; 1998; 62(14):1231-41. PubMed ID: 9570338 [TBL] [Abstract][Full Text] [Related]
31. Macromolecular prodrugs. XV. Colon-targeted delivery--bioavailability of naproxen from orally administered dextran-naproxen ester prodrugs varying in molecular size in the pig. Harboe E; Larsen C; Johansen M; Olesen HP Pharm Res; 1989 Nov; 6(11):919-23. PubMed ID: 2480587 [TBL] [Abstract][Full Text] [Related]
32. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043 [TBL] [Abstract][Full Text] [Related]
33. Oral delivery of peptide drugs: barriers and developments. Hamman JH; Enslin GM; Kotzé AF BioDrugs; 2005; 19(3):165-77. PubMed ID: 15984901 [TBL] [Abstract][Full Text] [Related]
34. Prodrug strategies for antihypertensives. Dhaneshwar SS; Sharma M; Patel V; Desai U; Bhojak J Curr Top Med Chem; 2011; 11(18):2299-317. PubMed ID: 21671866 [TBL] [Abstract][Full Text] [Related]
35. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats. Choi JS; Shin SC Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561 [TBL] [Abstract][Full Text] [Related]
36. Current prodrug design for drug discovery. Hsieh PW; Hung CF; Fang JY Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, in vitro antiviral evaluation, and stability studies of bis(S-acyl-2-thioethyl) ester derivatives of 9-[2-(phosphonomethoxy)ethyl]adenine (PMEA) as potential PMEA prodrugs with improved oral bioavailability. Benzaria S; Pélicano H; Johnson R; Maury G; Imbach JL; Aubertin AM; Obert G; Gosselin G J Med Chem; 1996 Dec; 39(25):4958-65. PubMed ID: 8960556 [TBL] [Abstract][Full Text] [Related]